Study highlights ongoing challenges in treating deprivation amblyopia despite surgical advances
A new publication by Lawrence Tychsen, MD, and William C. Carter, explores whether visual outcomes have improved for infants born with unilateral cataracts, a condition that can lead to severe deprivation amblyopia if left untreated.
The article, “Have Deprivation Amblyopia Outcomes Improved for Infants With Unilateral Cataracts?”, examines decades of progress in pediatric cataract surgery and the persistent challenges that remain in restoring vision to the affected eye.
Although advances in microsurgical technology, surgical techniques, and earlier intervention have made cataract removal safer and more effective than ever, the authors note that visual outcomes have not improved substantially over the past 40 years. The primary obstacle is not the surgery itself, but the intensive postoperative care required during infancy.
Following cataract removal, parents must patch the stronger eye for several hours each day and ensure that a contact lens is worn continuously in the treated eye to provide proper visual focus. These therapies are essential to stimulate visual development but can be difficult for families to maintain consistently.
“Advances in eye surgery micromachinery have made removal of the cataract easy,” said Tychsen. “The hard part is the home after-care: keeping an eye patch on the good eye and a contact lens in the lazy eye.”
The authors suggest that new pharmacological approaches to amblyopia treatment may help address these longstanding challenges and improve outcomes for future patients.
Their work underscores the importance of continued innovation not only in surgical care, but also in therapies that support visual development during the critical early years of life.
About WashU Medicine
WashU Medicine is a global leader in academic medicine, including biomedical research, patient care and educational programs with 2,900 faculty. Its National Institutes of Health (NIH) research funding portfolio is the second largest among U.S. medical schools and has grown 56% in the last seven years. Together with institutional investment, WashU Medicine commits well over $1 billion annually to basic and clinical research innovation and training. Its faculty practice is consistently within the top five in the country, with more than 1,900 faculty physicians practicing at 130 locations and who are also the medical staffs of Barnes-Jewish and St. Louis Children’s hospitals of BJC HealthCare. WashU Medicine has a storied history in MD/PhD training, recently dedicated $100 million to scholarships and curriculum renewal for its medical students, and is home to top-notch training programs in every medical subspecialty as well as physical therapy, occupational therapy, and audiology and communications sciences.